ACHE and Alzheimer disease: AD patients treated with AChE inhibitors exhibited a lower risk of hip fracture and stepped forward bone healing, indicating the damaged parasympathetic signalling affects bone homeostasis and might be a target to improve the bone health of AD patients (35).